First, Let's Start With Questions Based On Your Opinion ✓ Solved

First, let's start with questions based on your opinion: Wha

First, let's start with questions based on your opinion: What is the single most important action that you can take to prevent developing an infectious disease? Why? Scenario: Alex is an Events Manager for a regional sports team and always on the go. He recently noticed lesions on his skin that looked like large moles. Months later he was tested and received a diagnosis of HIV with AIDS. He is shocked and confused and knows little about anatomy or physiology. As his nurse, explain to him: 1. How the immune and integumentary systems work together to prevent and respond to disease and how HIV alters the body's ability to protect itself. 2. Using the chain of infection, explain how a virus like HIV could have infected him. 3. How an opportunistic infection could develop and why Kaposi's sarcoma occurs. 4. How he can prevent transmitting the virus to others.

Paper For Above Instructions

Opinion: Single Most Important Action to Prevent Infectious Disease

In my opinion, the single most important action to prevent developing an infectious disease is consistent, appropriate hand hygiene. Effective hand hygiene (handwashing with soap and water or using alcohol-based hand rubs) interrupts transmission of many pathogens by removing or killing microorganisms that are transferred by touch, which is a common route for respiratory, enteric, and contact-spread infections (WHO, 2009). Hand hygiene is simple, low-cost, broadly protective across pathogens, and reduces community and healthcare-associated infections (CDC, 2020). For pathogens transmitted primarily by sexual contact or blood (e.g., HIV), other actions such as condom use, safe injection practices, and access to PrEP/ART are essential; however, for general infectious disease prevention across populations and settings, hand hygiene offers the greatest broad benefit (WHO, 2009; CDC, 2020).

How the Immune and Integumentary Systems Work Together

The integumentary system (skin and associated structures) is the body’s first physical barrier against pathogens. Intact skin and mucous membranes block microbial entry, produce antimicrobial peptides, and support resident microbiota that compete with potential invaders (Tortora & Derrickson, 2017). When skin is breached, innate immune responses are activated: tissue-resident macrophages, dendritic cells, and neutrophils recognize pathogens via pattern-recognition receptors, engulf microbes, and release inflammatory mediators to recruit additional immune cells (Janeway et al., 2005).

The adaptive immune system (B and T lymphocytes) mounts specific, long-lasting responses. CD4+ T helper cells coordinate immune responses by activating macrophages and helping B cells make antibodies; CD8+ cytotoxic T cells kill infected host cells (Abbas et al., 2014). The skin and mucosa present antigen to local dendritic cells, which migrate to lymph nodes to prime adaptive responses, linking integumentary defenses and systemic immunity (Janeway et al., 2005).

HIV selectively infects and destroys CD4+ T helper cells and other target cells (e.g., macrophages), undermining adaptive immunity (Douek et al., 2013). Loss of CD4+ cells impairs coordination of immune responses, reduces antibody production, and diminishes cellular cytotoxicity, allowing normally controlled microbes and oncogenic viruses to proliferate unchecked. The integumentary system may then show manifestations of opportunistic disease (e.g., persistent skin lesions) because local and systemic immune surveillance are compromised (CDC, 2022).

Chain of Infection: How HIV Could Have Infected Alex

The chain of infection includes: infectious agent, reservoir, portal of exit, mode of transmission, portal of entry, and susceptible host. Applied to HIV:

  1. Agent: Human Immunodeficiency Virus (HIV), a retrovirus that infects immune cells.
  2. Reservoir: An infected human (someone with circulating virus in blood, semen, vaginal fluids, rectal fluids, or breast milk).
  3. Portal of exit: Virus leaves the reservoir through blood or sexual fluids during sex, shared injection equipment, transfused blood (rare in screened supplies), or perinatal exposure (birth or breastfeeding) (CDC, 2022).
  4. Mode of transmission: Sexual transmission (unprotected anal or vaginal intercourse), parenteral (shared needles), perinatal (mother-to-child), or occupational exposures (needle stick) (WHO, 2021).
  5. Portal of entry: Mucous membranes, microabrasions in skin, or direct bloodstream inoculation.
  6. Susceptible host: A person without protective immunity or on insufficient prophylaxis (e.g., Alex), particularly if exposed during high-risk acts.

Based on this, Alex could have been infected through an unprotected sexual encounter, shared injection equipment, or another route where viral fluids contacted a mucosal surface or bloodstream. Because HIV transmission requires specific exposures to infectious fluids, understanding and interrupting links in this chain (e.g., eliminating exposure, reducing virus in the reservoir with ART) prevents infection (Cohen et al., 2016).

Why Opportunistic Infections Develop and Why Kaposi’s Sarcoma Occurs

Opportunistic infections occur when immune defenses drop below the level needed to contain normally latent or low-virulence organisms. In HIV infection, progressive depletion of CD4+ T cells (and dysfunction of innate immune cells) permits reactivation of latent pathogens (e.g., Mycobacterium avium, Pneumocystis jirovecii, cytomegalovirus) and uncontrolled growth of microbes that are otherwise held in check (CDC, 2022).

Kaposi’s sarcoma (KS) is a vascular tumor caused by human herpesvirus 8 (HHV-8, also called KSHV). In immunocompetent hosts HHV-8 is often suppressed, but in the setting of profound immunosuppression (e.g., AIDS), HHV-8–infected endothelial cells proliferate and produce characteristic violaceous cutaneous lesions and sometimes visceral disease (Chang & Moore, 1996; Gallo & Cossart, 2015). The skin lesions Alex described (“large moles”) are consistent with KS; their appearance is common in AIDS patients because both immune suppression and HHV-8 co-infection are necessary factors (Moore & Chang, 1998). Effective antiretroviral therapy often reduces KS progression by restoring immune control over HHV-8 (Krown et al., 2008).

How Alex Can Prevent Transmitting HIV to Others

Key prevention strategies Alex can use and discuss with partners include:

  • Start and adhere to antiretroviral therapy (ART) immediately. Sustained viral suppression makes sexual transmission effectively negligible (U=U: undetectable = untransmittable) (Cohen et al., 2016; CDC, 2021).
  • Use condoms consistently and correctly during sexual activity to reduce risk until viral suppression is confirmed and maintained (WHO, 2021).
  • Avoid sharing needles; if injection drug use occurs, use sterile equipment and harm-reduction services (syringe programs, supervised consumption sites) (CDC, 2019).
  • Inform sexual partners and encourage testing; partners may consider pre-exposure prophylaxis (PrEP) if at continued risk (CDC, 2021).
  • For occupational exposures or recent high-risk exposures, seek immediate post-exposure prophylaxis (PEP) within 72 hours (CDC, 2019).
  • Regular follow-up with HIV care to monitor CD4 count, viral load, and screen/treat opportunistic infections; treat KS and other conditions as indicated (WHO, 2021).

Explaining these steps to Alex in plain language—ART will suppress the virus, condoms and safe practices reduce immediate risk, and regular care prevents complications—can reduce anxiety and empower him to protect himself and others (Mayo Clinic, 2023).

Conclusion

Summarized for Alex: the skin and immune cells work together to block and fight infections; HIV targets the immune system’s key coordinators (CD4+ cells), allowing opportunistic diseases like Kaposi’s sarcoma to appear. HIV most commonly spreads when infectious bodily fluids contact mucous membranes or blood; preventing transmission means stopping those exposures (condoms, clean needles), and most powerfully, achieving and maintaining undetectable viral load with ART (U=U). For general infectious disease prevention across many pathogens, consistent hand hygiene is the single most broadly effective measure he can adopt in daily life (WHO, 2009; CDC, 2020).

References

  • Centers for Disease Control and Prevention (CDC). HIV Basics. CDC. 2022. https://www.cdc.gov/hiv/basics/index.html
  • World Health Organization (WHO). HIV/AIDS. WHO. 2021. https://www.who.int/health-topics/hiv-aids
  • Cohen MS, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. New England Journal of Medicine. 2016;375(9):830–839.
  • World Health Organization. WHO Guidelines on Hand Hygiene in Health Care. 2009. https://www.who.int/gpsc/5may/tools/en/
  • Tortora GJ, Derrickson B. Principles of Anatomy and Physiology. 15th ed. Wiley; 2017.
  • Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. 9th ed. Elsevier; 2018.
  • Chang Y, Moore PS. Kaposi's sarcoma-associated herpesvirus. Current Topics in Microbiology and Immunology. 1996;201:63–87.
  • Mayo Clinic. HIV/AIDS - Diagnosis and Treatment. Mayo Clinic. 2023. https://www.mayoclinic.org/diseases-conditions/hiv-aids/diagnosis-treatment
  • Krown SE, et al. Kaposi sarcoma in HIV-infected patients: treatment and prognosis. Journal of Clinical Oncology. 2008;26(21):3415–3422.
  • Centers for Disease Control and Prevention (CDC). Pre-exposure Prophylaxis (PrEP). CDC. 2021. https://www.cdc.gov/hiv/basics/prep.html

Related Assignments